dual tau/Ab oligomerization inhibitors (Treventis/Servier)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual tau/Ab oligomerization inhibitors (Treventis/Servier)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTreventis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTreventis CorpLaboratoires Servier
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A